Stoke Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor

Stoke Therapeutics, Inc.

Elected Jennifer C. Burstein, Arthur A. Levin, Ph.D., and Ian F. Smith as Class II directors for three-year terms.
Burstein received 32,396,633 votes for; Levin 25,556,568 for; Smith 33,961,032 for; broker non-votes 5,561,508 each.
Ratified KPMG as independent auditor for fiscal 2024 with 39,911,634 votes for, 6,826 against, 9,898 abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.